全國(guó)26家醫(yī)療衛(wèi)生機(jī)構(gòu)藥品短缺原因的調(diào)查分析
本文選題:醫(yī)療衛(wèi)生機(jī)構(gòu) 切入點(diǎn):藥品短缺 出處:《中國(guó)藥房》2017年27期 論文類型:期刊論文
【摘要】:目的:為保障短缺藥品供應(yīng)提供參考。方法:采用問(wèn)卷調(diào)查方式對(duì)全國(guó)40家醫(yī)療衛(wèi)生機(jī)構(gòu)的藥品短缺情況進(jìn)行實(shí)地調(diào)查,基于調(diào)查數(shù)據(jù)構(gòu)建計(jì)量模型對(duì)醫(yī)療衛(wèi)生機(jī)構(gòu)藥品短缺原因進(jìn)行實(shí)證分析。結(jié)果:共發(fā)放問(wèn)卷40份,回收有效問(wèn)卷26份,有效回收率為65.0%。受訪機(jī)構(gòu)中共獲得87個(gè)短缺藥品樣本,涉及33種藥品;82.8%的短缺藥品樣本的短缺時(shí)間超過(guò)3個(gè)月,甚至有21.8%短缺時(shí)間超過(guò)12個(gè)月。導(dǎo)致藥品短缺程度更高的共性原因主要為:未進(jìn)入省級(jí)招標(biāo)目錄、采用政府定價(jià)方式、存在調(diào)劑使用機(jī)制和未設(shè)立省級(jí)常態(tài)化儲(chǔ)備機(jī)制。除共性原因外,導(dǎo)致藥品短缺程度更高尚有基于臨床需求必要性、基于藥品屬性(常用、罕見(jiàn))、基于藥品價(jià)格等方面的一些個(gè)性原因。結(jié)論:影響醫(yī)療衛(wèi)生機(jī)構(gòu)藥品短缺程度的原因有多種,其中既有共性原因也有個(gè)性原因,要從源頭解決藥品短缺問(wèn)題需要多方面的政策和制度配合實(shí)施。
[Abstract]:Objective: to provide a reference for guaranteeing the shortage of drugs. Methods: a questionnaire survey was conducted to investigate the drug shortage in 40 medical and health institutions in China. Based on the survey data, a quantitative model was constructed to analyze the causes of drug shortage in medical and health institutions. Results: a total of 40 questionnaires were distributed, 26 valid questionnaires were recovered, and the effective recovery rate was 65.0. 87 drug shortage samples were obtained from the institutions surveyed. The shortage time of the samples involving 82.8% of the 33 kinds of drugs is more than 3 months, or even 21.8% of the shortage time is more than 12 months. The common reasons leading to the higher degree of drug shortage are: not entering the provincial bidding list and adopting the government pricing method. In addition to the common reasons, the higher degree of drug shortage is based on the necessity of clinical demand, and based on the properties of drugs. Conclusion: there are many reasons that affect the degree of drug shortage in medical and health institutions, among which there are both common and individual reasons. To solve the drug shortage problem from the source, many policies and systems are needed.
【作者單位】: 中國(guó)藥科大學(xué)國(guó)際醫(yī)藥商學(xué)院;
【基金】:工信部課題資助項(xiàng)目(No.X153030)
【分類號(hào)】:R95
【相似文獻(xiàn)】
相關(guān)期刊論文 前7條
1 劉華;孫利華;;北京市醫(yī)療衛(wèi)生機(jī)構(gòu)藥品采購(gòu)存在的問(wèn)題與對(duì)策[J];中國(guó)藥房;2013年05期
2 陳慧;莊文斌;陳吉生;;不同級(jí)別的醫(yī)療衛(wèi)生機(jī)構(gòu)短缺基本藥物相關(guān)情況的調(diào)查分析[J];中國(guó)藥房;2014年16期
3 馬潔;周宇行;方寧;沈兆震;;區(qū)域內(nèi)醫(yī)療衛(wèi)生機(jī)構(gòu)藥品采購(gòu)網(wǎng)上統(tǒng)一結(jié)算支付的研究[J];江蘇衛(wèi)生事業(yè)管理;2012年02期
4 ;省物價(jià)局關(guān)于嚴(yán)格規(guī)范醫(yī)療衛(wèi)生機(jī)構(gòu)銷售藥品加價(jià)行為有關(guān)政策的通知[J];湖北省人民政府公報(bào);2008年01期
5 謝頂仁;楊華萍;朱臘榮;張友干;;醫(yī)療衛(wèi)生機(jī)構(gòu)在執(zhí)行《麻醉藥品和精神藥品管理?xiàng)l例》過(guò)程中存在的問(wèn)題及對(duì)策[J];中國(guó)藥房;2013年25期
6 閆峻峰;陳鳴;童榮生;陳岷;江濤;程靜;;不同等級(jí)不同類型醫(yī)療衛(wèi)生機(jī)構(gòu)使用國(guó)家基本藥物的考核標(biāo)準(zhǔn)研究[J];中國(guó)藥房;2013年40期
7 張超;潘木善;;醫(yī)療衛(wèi)生機(jī)構(gòu)藥品價(jià)格虛高的原因分析與對(duì)策[J];中國(guó)藥房;2012年24期
相關(guān)重要報(bào)紙文章 前3條
1 記者 吳穎;重慶規(guī)劃基本藥物保障體系[N];健康報(bào);2009年
2 首席記者 曹政;江蘇短缺藥品實(shí)行分類管理[N];健康報(bào);2014年
3 記者 張亦筑;醫(yī)院藥品信息今后上網(wǎng)可查詢[N];重慶日?qǐng)?bào);2011年
,本文編號(hào):1649547
本文鏈接:http://sikaile.net/yixuelunwen/yiyaoxuelunwen/1649547.html